Metformin, hepatitis C, and insulin resistance: Sufficient evidence?
β Scribed by Yusuf Yilmaz; Oya Yonal; Nese Imeryuz
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 103 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatic steatosis is common in chronic hepatitis C and has been linked to concurrent obesity, insulin resistance, diabetes, disease severity, and poor response to therapy. Racial differences in rates of obesity and diabetes may contribute to racial differences in hepatic steatosis and treatment resp
I read with interest the timely article by Bugianesi et al. detailing insulin resistance in chronic liver disease. As briefly mentioned in this article, chronic hepatitis C (CHC) is associated with insulin resistance (IR) and the co-existence of NAFLD and IR with CHC is associated with decreased su
Insulin resistance affects sustained virological response (SVR) in chronic hepatitis C. To know whether adding metformin to standard antiviral treatment improves SVR, we conducted a prospective, multicentered, randomized, double-blinded, placebo-controlled trial in 19 Spanish hospitals, including 12